Literature DB >> 10805366

Effect of imiquimod on cytokine induction in first trimester trophoblasts.

J M Manlove-Simmons1, F M Zaher, M Tomai, B Gonik, D M Svinarich.   

Abstract

OBJECTIVES: Imiquimod (IQ) is used clinically for the topical treatment of external genital warts. IQ is an immune response modifier and induces the expression of interferon-alpha and other cytokines in human Peripheral Blood Monocytes (PBMC). Trophoblasts have been previously shown to express inflammatory cytokines upon lipopolysaccharide (LPS) stimulation. The objective of this study was to evaluate the ability of IQ to induce transcription of cytokines in trophoblasts.
METHODS: A transformed human first trimester trophoblast cell line, HTR-8/SVneo, was cultured in DMEM containing IQ at concentrations of 0 to 5.0 microg/ml. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) viability assays were conducted to control for any drug-induced cell death. Total RNA was isolated from trophoblasts at 0, 8 and 24 hours of culture and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was conducted using specific amplimers for the inflammatory cytokines interleukin (IL)-1alpha, IL-1beta, IL-6 and IL-8. RT-PCR of beta-actin was performed to control for equal RNA loading.
RESULTS: RT-PCR was unable detect an increase in either IL-1alpha, IL-1beta, IL-6 or IL-8 mRNA in first trimester trophoblasts cultured in the presence of 0 to 5.0 microg/mL of IQ for up to 24 hours. RT-PCR confirmed equal RNA loading and MTT viability assays did not show loss of cell viability at concentrations of IQ up to 5.0 microg/ml.
CONCLUSIONS: IQ, at the concentrations tested, did not induce the transcriptional expression of inflammatory cytokines in human first trimester trophoblasts. These data suggest that IQ would not induce the expression of inflammatory cytokines in placental trophoblasts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805366      PMCID: PMC1784669          DOI: 10.1002/(SICI)1098-0997(2000)8:2<105::AID-IDOG8>3.0.CO;2-H

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  11 in total

Review 1.  Immune signalling at the maternal-fetal interface and trophoblast differentiation.

Authors:  T G Wegmann; L J Guilbert
Journal:  Dev Comp Immunol       Date:  1992 Nov-Dec       Impact factor: 3.636

2.  Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

Authors:  K R Beutner; S K Tyring; K F Trofatter; J M Douglas; S Spruance; M L Owens; T L Fox; A J Hougham; K A Schmitt
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Induction and posttranslational expression of cytokines in a first-trimester trophoblast cell line by lipopolysaccharide.

Authors:  D M Svinarich; O M Bitonti; R Romero; B Gonik
Journal:  Am J Obstet Gynecol       Date:  1996-10       Impact factor: 8.661

4.  Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro.

Authors:  C E Weeks; S J Gibson
Journal:  J Interferon Res       Date:  1994-04

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

Authors:  L Edwards; A Ferenczy; L Eron; D Baker; M L Owens; T L Fox; A J Hougham; K A Schmitt
Journal:  Arch Dermatol       Date:  1998-01

7.  Induction and postranslational expression of G-CSF and RANTES in a first trimester trophoblast cell line by lipopolysaccharide.

Authors:  D M Svinarich; O M Bitonti; H Araneda; R Romero; B Gonik
Journal:  Am J Reprod Immunol       Date:  1996-11       Impact factor: 3.886

8.  Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609.

Authors:  S J Gibson; L M Imbertson; T L Wagner; T L Testerman; M J Reiter; R L Miller; M A Tomai
Journal:  J Interferon Cytokine Res       Date:  1995-06       Impact factor: 2.607

9.  Inflammatory mediators regulate interleukin-8 production by cultured gestational tissues: evidence for a cytokine network at the chorio-decidual interface.

Authors:  D J Dudley; M S Trautman; M D Mitchell
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

10.  Cytokine induction by the immunomodulators imiquimod and S-27609.

Authors:  T L Testerman; J F Gerster; L M Imbertson; M J Reiter; R L Miller; S J Gibson; T L Wagner; M A Tomai
Journal:  J Leukoc Biol       Date:  1995-09       Impact factor: 4.962

View more
  1 in total

1.  Regulation of human placental drug transporters in HCV infection and their influence on direct acting antiviral medications.

Authors:  Emily Pfeifer; Jessica Parrott; Gene T Lee; Ericka Domalakes; Helen Zhou; Lily He; Clifford W Mason
Journal:  Placenta       Date:  2018-07-10       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.